In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chloe Kent

Reporter

Chloe is an award-winning journalist who has specialized in health reporting throughout her career, with a particular focus on women's health and access to medicine. Before joining Generics Bulletin she worked for B2B publishing consortium Verdict, writing about medical technology and pharmaceuticals. Having graduated from the University of York, she went on to train as a journalist with the Press Association.

Latest From Chloe Kent

EMA And HMA Speak Out In Favor Of Biosimilar Interchangeability

Stakeholders in Europe have been hesitant to allow interchangeable substitution of biological products, prompting the European Medicines Agency to clarify its stance on the issue.

Biosimilars Europe

MPP Teams Up With MedinCell For Investigational Malaria Transmission Treatment

The Medicines Patent Pool has secured a licensing deal with MedinCell for a long-acting injectable ivermectin drug formulation which could be used to prevent ongoing spread of malaria.

Deals Intellectual Property

Earnings Recovery For Nichi-Iko Unlikely Before Full Resumption Of Toyama Shipments

Nichi-Iko still has a long road to recovery ahead as it attempts to get its Toyama plant back on its feet.

Sales & Earnings Strategy

US Patients Increasingly Reliant On Pharmacy Discount Cards For Generics

IQVIA has published a white paper examining the growing reliance on pharmacy discount cards to pay for prescriptions in the US.

Pricing Strategies Generic Drugs

All About Unlocking Eve: The Initiative Advancing Women In Healthcare Leadership

In Vivo's Chloe Kent discussed the future of women in healthcare leadership with Roche executives and Unlocking Eve founders Eva McLellan and Kaye Vitug.

Diversity & Inclusion Leadership

Clinical Efficacy And Safety Studies 'Redundant' For Most Biosimilars

A team of researchers has concluded that in vivo animal studies and large safety and efficacy studies are rarely necessary to license biosimilars.

Biosimilars Drug Approval Standards
See All
UsernamePublicRestriction

Register